Zilver PTX RCT mortality analysis: no difference in long-term mortality rate for Zilver PTX drug-eluting stent compared to PTA/BMS.

Authors

• Michael D Dake
• Gary M Ansel, OhioHealth
• Aaron E Lottes

Document Type

Article

Publication Title

CVIR endovascular

First Page

25

Last Page

25

DOI

10.1186/s42155-019-0069-x

Publication Date

7-27-2019

Recommended Citation

Dake MD, Ansel GM, Lottes AE. Zilver PTX RCT mortality analysis: no difference in long-term mortality rate for Zilver PTX drug-eluting stent compared to PTA/BMS. CVIR Endovasc. 2019 Jul 27;2(1):25. doi: 10.1186/s42155-019-0069-x. PMID: 32027000; PMCID: PMC6966343.